Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 8Phase 3 5Phase 2/3 2Phase 1 2Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Other solid neoplasm 1Gynecologic 1Breast 1

Conditions

Glioblastoma 12Astrocytoma 11Glioma 10Brain Neoplasms 9Gliosarcoma 7Oligodendroglioma 6Central Nervous System Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Non-Small-Cell Lung 5Rectal Neoplasms 4Breast Neoplasms 4Meningioma 3Esophageal Neoplasms 3Colorectal Neoplasms 3Stomach Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Recurrence 2Pinealoma 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Medulloblastoma 2Craniopharyngioma 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Prostatic Neoplasms 1Pathologic Complete Response 1Ovarian Neoplasms 1

Interventions

pembrolizumab 28Cisplatin 24Oxaliplatin 22Irinotecan 22Fluorouracil 22Capecitabine 20Leucovorin 17Paclitaxel 16Cyclophosphamide 14Trastuzumab 12Nivolumab 11Carboplatin 11Gemcitabine 10Bevacizumab 10Docetaxel 9fludarabine 8aldesleukin 8S 1 (combination) 8Ramucirumab 7130-nm albumin-bound paclitaxel 7atezolizumab 6Albumin-Bound Paclitaxel 6Taxes 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Biopsy 5veliparib 4tislelizumab 4spartalizumab 4dehydroftorafur 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Stomach Neoplasms × Surgical Procedures, Operative × Clear all
NCT06281860 2024-02-28

PITHAC

Centre Hospitalier Universitaire Vaudois

Phase 1 Unknown
39 enrolled
BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT01561014 2018-07-02

Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Wake Forest University Health Sciences

Phase 1 Completed
9 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡